Johns Hopkins HIV Guide
Zidovudine (AZT)
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretrovirals.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: February 12, 2022
Citation
Kilcrease, Christin. "Zidovudine (AZT)." Johns Hopkins HIV Guide, 2022. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545223/all/Zidovudine__AZT_.
Kilcrease C. Zidovudine (AZT). Johns Hopkins HIV Guide. 2022. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545223/all/Zidovudine__AZT_. Accessed June 1, 2023.
Kilcrease, C. (2022). Zidovudine (AZT). In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545223/all/Zidovudine__AZT_
Kilcrease C. Zidovudine (AZT) [Internet]. In: Johns Hopkins HIV Guide. ; 2022. [cited 2023 June 01]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545223/all/Zidovudine__AZT_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Zidovudine (AZT)
ID - 545223
A1 - Kilcrease,Christin,Pharm.D.
Y1 - 2022/02/12/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545223/all/Zidovudine__AZT_
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
